You're about to write the death notice for Percheron, to follow the slow, painful death of NeuroBo, Kazia, Patrys, a litany of disasters.
Every experienced biotech/pharma executive or investment advisor will tell you to stay away from neurological biotech investments as there's a graveyard of well-funded programs that have failed over the decades and any new developments have a very low chance of success.
That's no problem for the Board who can milk the company dry in the next few years, especially with JG on his million dollar package plus extras.
And before the clown (or anyone else) tells me to sell and go away, I have to hang on for the time-being to vote against this current Board .... I don't like the alternative too much but the current path is definitely into administration....slowly and painfully.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)